Biotech investors in DACH
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate. Bonn, Germany |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 28% | 5 |
| 2 | BlueYard Capital BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio. Berlin, Germany |
Fintech, Biotech | Seed, Early stage venture | 41% | 3 |
| 3 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 3 |
| 4 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
| 5 | Nucleus Capital Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia. Berlin, Germany |
Biotech, Health care | Seed, Early stage venture | 32% | 2 |
Table 1. Biotech investors in DACH: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | •••@htgf.de | +49 22••• |
| Venture Kick | Startup incubator | Schlieren, Switzerland | •••@venturekick.ch | +41 (2••• |
| KfW | Government investment office | Frankfurt, Germany | •••@kfw.de | 49 69 ••• |
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| Bayern Kapital | Venture capital firm | Landshut, Germany | •••@bayernkapital.de | +49871••• |
| BioMedPartners | Venture capital firm | Basel, Switzerland | •••@biomedvc.com | +41 61••• |
| Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | •••@fondation-fit.ch | +41 21••• |
| Verve Ventures | Venture capital firm | Zug, Switzerland | •••@verve.vc |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 75 of the 97 biotech investors in DACH have a published email address, 60 a phone number and 96 a website.
- HTGF (High-Tech Gruenderfonds) has the most recorded investments, 1,026, 290 of them as lead investor.
- 58 of them are investors in at least one company that closed its most recent round in the last 12 months.
- HTGF (High-Tech Gruenderfonds) is an investor in 17 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Zafrens' $6.0M Series A on 3 November 2026.
- Software is the most common sector across their 1,731 portfolio companies (66%).
- Early stage venture is the most common investment stage, recorded for 88 of them (91%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in DACH
30 of 97, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | Biotech, Health care | Rabot Energy, CereGate, syte | 17 | 1,026 | 290 | 136 | •••@htgf.de | +49 22••• | In the CSV |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | Health care, Biotech | UniSieve, Cotierra, Jaipur Robotics | 13 | 1,459 | 1,342 | 82 | •••@venturekick.ch | +41 (2••• | In the CSV |
| 3 | KfW | Government investment office, Investment bank | Frankfurt, Germany | Biotech, Health care | CryoTherapeutics, Vectoflow, HelloDuty | 198 | 29 | 56 | •••@kfw.de | 49 69 ••• | In the CSV | |
| 4 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 5 | Bayern Kapital | Venture capital firm | Landshut, Germany | Health care, Artificial intelligence | mbiomics, SPiNE, Driveblocks | 4 | 294 | 41 | 41 | •••@bayernkapital.de | +49871••• | In the CSV |
| 6 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | Biotech, Health care | smartbax, xCures, Tacalyx | 4 | 99 | 47 | 12 | +49 61••• | ||
| 7 | BioMedPartners | Venture capital firm | Basel, Switzerland | Biotech, Health care | TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics | 87 | 29 | 22 | •••@biomedvc.com | +41 61••• | In the CSV | |
| 8 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program, Government investment office | Lausanne, Switzerland | Health care, Biotech | Adaptyv Biosystems, Carewell, Alithea Genomics | 7 | 345 | 329 | 35 | •••@fondation-fit.ch | +41 21••• | In the CSV |
| 9 | Verve Ventures | Venture capital firm | Zug, Switzerland | Health care, Artificial intelligence | Stake, Nuclera | 2 | 275 | 37 | 35 | •••@verve.vc | In the CSV | |
| 10 | Innosuisse | Government investment office | Berne, Switzerland | Health care, Biotech | UniSieve, KEMARO AG, Seprify | 6 | 232 | 184 | 13 | •••@innosuisse.ch | +41 58••• | In the CSV |
| 11 | Wellington Partners | Venture capital firm | Munich, Germany | Health care, Biotech | nyra health | 1 | 252 | 80 | 65 | •••@wellington-partners.com | +44 20••• | In the CSV |
| 12 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | Biotech, Artificial intelligence | Treeless, Perovskia, SolidWatts | 5 | 227 | 219 | 2 | In the CSV | ||
| 13 | NRW.BANK | Government investment office, Investment bank | Düsseldorf, Germany | Artificial intelligence, Biotech | Lumoview Building Analytics, Elixion Medical, Alteva | 126 | 28 | 17 | •••@nrwbank.de | +32 2 ••• | In the CSV | |
| 14 | VI Partners | Venture capital firm | Altendorf, Switzerland | Health care, Biotech | L.E.S.S. | 1 | 111 | 26 | 22 | •••@vipartners.ch | +41 41••• | In the CSV |
| 15 | MIG Capital | Venture capital firm | Munich, Germany | Biotech, Health care | NavVis, mbiomics | 2 | 95 | 43 | 15 | •••@mig.ag | In the CSV | |
| 16 | Leaps by Bayer | Corporate venture arm | Leverkusen, Germany | Health care, Biotech | 9amHealth, CORXEL Pharmaceuticals | 2 | 113 | 45 | 13 | In the CSV | ||
| 17 | BlueYard Capital | Venture capital firm | Berlin, Germany | Fintech, Biotech | Zafrens, Castelion, Transcripta Bio | 7 | 102 | 42 | 4 | +49 61••• | In the CSV | |
| 18 | German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | Biotech, Health care | eClear, NVision Quantum Technologies | 2 | 62 | 39 | 13 | •••@bmftr.bund.de | +49 (0••• | In the CSV |
| 19 | APEX Ventures | Venture capital firm | Vienna, Austria | Health care, Artificial intelligence | OKAPI:Orbits, Quibim, Lyfegen | 58 | 17 | 2 | •••@apex.ventures | (516) ••• | In the CSV | |
| 20 | Fraunhofer Venture | Venture capital firm | Munich, Germany | Biotech, Health care | Cellbox Solutions | 1 | 40 | 6 | 5 | •••@fraunhoferventure.de | +49 89••• | In the CSV |
| 21 | Pureos Bioventures | Venture capital firm | Küsnacht, Switzerland | Biotech, Health care | NovaGo Therapeutics | 1 | 35 | 13 | 6 | In the CSV | ||
| 22 | HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | Biotech, Health care | 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics | 260 | 47 | 90 | •••@hbmhealthcare.com | +41 41••• | ||
| 23 | redalpine | Venture capital firm | Zürich, Switzerland | Artificial intelligence, Fintech | Basecamp Research, Albatross AI | 2 | 188 | 69 | 22 | •••@redalpine.com | +41 44••• | In the CSV |
| 24 | Possible Ventures | Venture capital firm | Munich, Germany | Hardware, Artificial intelligence | Antaris, Arlula, InSpacePropulsion Technologies | 4 | 152 | 9 | 9 | In the CSV | ||
| 25 | IFB Innovationsstarter | Venture capital firm | Hamburg, Germany | Health care, Biotech | recalm, apoQlar, SupplyET | 88 | 35 | 6 | +49 40••• | In the CSV | ||
| 26 | LBBW VC | Corporate venture arm | Stuttgart, Germany | Biotech, Health care | Exciva | 1 | 47 | 14 | 7 | +49 71••• | In the CSV | |
| 27 | Nucleus Capital | Venture capital firm | Berlin, Germany | Biotech, Health care | Apoha, Biomia | 2 | 44 | 14 | 2 | In the CSV | ||
| 28 | Amino Collective | Venture capital firm | Berlin, Germany | Health care, Biotech | Tandem Health, Rivia, Biomia | 3 | 42 | 2 | 2 | •••@aminocollective.com | In the CSV | |
| 29 | EMBL Ventures | Venture capital firm | Heidelberg, Germany | Biotech, Health care | Luxendo, Allecra Therapeutics, ImevaX | 20 | 5 | 6 | •••@embl-ventures.com | +49 (6••• | In the CSV | |
| 30 | b.value AG | Venture capital firm | Dortmund, Germany | Biotech, Health care | Cellbricks Therapeutics | 1 | 13 | 3 | 0 | •••@b-value.de | +49 (0••• | In the CSV |
Table 2. Biotech investors in DACH: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 97.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Bonn, Germany | 17 | 257 | Rabot Energy, CereGate, syte |
| 2 | Venture Kick | Schlieren, Switzerland | 13 | 129 | UniSieve, Cotierra, Jaipur Robotics |
| 3 | Picus Capital | Munich, Germany | 8 | 69 | Reflex, Baselayer, FINN |
| 4 | BlueYard Capital | Berlin, Germany | 7 | 25 | Zafrens, Castelion, Transcripta Bio |
| 5 | Earlybird Venture Capital | Berlin, Germany | 7 | 72 | finmid, ColibrITD, Quantum Diamonds |
| 6 | Foundation for Innovation and Technology (FIT) | Lausanne, Switzerland | 7 | 30 | Adaptyv Biosystems, Carewell, Alithea Genomics |
| 7 | Cherry Ventures | Berlin, Germany | 7 | 58 | Moss, Stenon, bunch |
| 8 | Innosuisse | Berne, Switzerland | 6 | 29 | UniSieve, KEMARO AG, Seprify |
| 9 | Speedinvest | Vienna, Austria | 6 | 136 | hexafarms, Nomos, Greyparrot |
| 10 | Leblon Capital | Munich, Germany | 5 | 38 | Mural, Rivio, Taktile |
| 11 | HV Capital | Munich, Germany | 5 | 72 | Rabot Energy, FINN, NEURA Robotics |
| 12 | MassChallenge Switzerland | Renens, Switzerland | 5 | 35 | Treeless, Perovskia, SolidWatts |
| 13 | Founderful | Zürich, Switzerland | 4 | 21 | UniSieve, Adaptyv Biosystems, Zuriq |
| 14 | TGFS - Technologiegründerfonds Sachsen | Leipzig, Germany | 4 | 22 | Prodlane, BirdsView, Peeriot |
| 15 | Boehringer Ingelheim Venture Fund | Ingelheim Am Rhein, Germany | 4 | 14 | smartbax, xCures, Tacalyx |
Table 3. Biotech investors in DACH: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Zafrens | Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. | Biotech | San Diego, United States | Series A | $6.0M | 2026-11-03 | $35.0M | BlueYard Capital | 11 to 50 | 2022 |
| Reflex | Reflex is an open-source Python framework for building and deploying web applications. | Software | San Francisco, United States | Series A | $14.0M | 2026-10-29 | $19.5M | Picus Capital | 11 to 50 | 2023 |
| Mural | Mural offers a financial platform for cross-border payments, fund transfers, and digital asset transactions. | Fintech | New York, United States | Series A | $15.0M | 2026-10-20 | $20.6M | Leblon Capital | 11 to 50 | 2022 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | Fraunhofer Venture | 11 to 50 | 2017 |
| Probably Genetic | Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. | Artificial intelligence | San Francisco, United States | Series A | $12.0M | 2026-10-15 | $22.9M | Calm/Storm VC | 11 to 50 | 2018 |
| Rabot Energy | Rabot Energy supplies green electricity with flexible and smart tariffs for homes and electric vehicles. | Energy | Hamburg, Germany | Series B | $56.1M | 2026-10-14 | $79.7M | HV Capital, HTGF (High-Tech Gruenderfonds) | 101 to 250 | 2021 |
| UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich, Switzerland | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, Founderful, Innosuisse | 11 to 50 | 2018 |
| finmid | finmid provides embedded lending infrastructure that powers platform growth. | Fintech | Berlin, Germany | Series A | $19.1M | 2026-10-06 | $58.0M | Earlybird Venture Capital | 11 to 50 | 2021 |
| hexafarms | Hexafarms develops AI-powered software and hardware for commercial greenhouse and protected-crop operations. | Software | Berlin, Germany | Seed | $5.4M | 2026-10-06 | $7.8M | Speedinvest | 11 to 50 | 2021 |
| Procuros | Procuros is a fintech company that automates manual B2B transactions into transparent flows. | Fintech | Hamburg, Germany | Series A | $22.3M | 2026-10-05 | $32.5M | SquareOne Venture Capital | 11 to 50 | 2021 |
Table 4. Biotech investors in DACH: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,151 | 66% |
| Health care | 404 | 23% |
| Artificial intelligence | 368 | 21% |
| Biotech | 330 | 19% |
| Hardware | 240 | 14% |
| Fintech | 235 | 14% |
| Commerce | 137 | 8% |
| Education | 61 | 4% |
| Energy | 60 | 3% |
| Cybersecurity | 46 | 3% |
Table 5. Biotech investors in DACH: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 88 | 91% |
| Seed investors | 70 | 72% |
| Late stage investors | 47 | 48% |
| Venture investors | 42 | 43% |
| Convertible note investors | 13 | 13% |
| Private equity investors | 12 | 12% |
| Debt investors | 8 | 8% |
| Grant makers | 8 | 8% |
Table 6. Biotech investors in DACH by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| Germany | 60 | 62% |
| Switzerland | 32 | 33% |
| Austria | 5 | 5% |
Table 7. Biotech investors in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 8. Biotech investors in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 6 | 7% |
| 2010s | 31 | 34% |
| 2000s | 32 | 35% |
| 1990s | 16 | 17% |
| 1980s | 1 | 1% |
| 1970s | 2 | 2% |
Table 9. Biotech investors in DACH by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in DACH. On 16 November 2026 that is 97 investors.
- 75 rows carry an email address and 60 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 97 rows: 1 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in DACH are on the list?
- 97, in the file dated 16 November 2026. 58 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 75 of the 97 carry an email address in the download and 60 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 97 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 97 rows, 75 firm email addresses and 60 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 59 of the 75 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.